Brief: Guard Therapeutics Patent Granted In Australia
Feb 11 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* GUARD THERAPEUTICS PATENT GRANTED IN AUSTRALIA
* OBTAINED PATENT PROTECTION IN AUSTRALIA FOR THEIR
BIOLOGICAL
INVESTIGATIONAL DRUG ROSGARD, BOTH AS PRODUCT AND FOR ITS USE IN
MEDICINE
* ALSO RECEIVED A NOTICE OF ALLOWANCE IN US.
Source text for Eikon: ID:nMFN2NYPk1
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover